BUY Colgate Palmolive (India) — Citigroup, 18 Aug 2026

byCitigroupHorizon: NA (inferred 1 year)18 Aug 2026via CNBC Awaaz.

Entry₹1,916Inferred

Target₹2,000

Stop lossNot given

CMP₹1,829.22d ago

Active-4.53%+9.34%upside left 12 mo left

Follow Citigroup for new calls(100% target hit, 20 closed calls)Get alerts Watch COLPAL for new buy/sell callsGet alerts See 12 other Long-term calls on COLPAL

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 4:49 am IST

12 supporting14 neutral5 opposing

Supports the BUY call (12)

Colgate-Palmolive (India) passes all resolutions at 85th AGM

NewsGoogle News·30 Aug · 1w ago

Colgate PerioGard has become India's first Gum Care regimen to receive the ISP Seal of Acceptance, as announced in a press release dated August 18, 2026.

NSE · Press Release·18 Aug · 3w ago

Colgate PerioGard has become India's first gum care regimen to receive the Indian Society of Periodontology (ISP) Seal of Acceptance. This recognition highlights the product's efficacy and safety, aim

BSE · Company Update·18 Aug · 3w ago

Colgate-Palmolive Signals Price Hikes Amid Rising Costs

NewsGoogle News·18 Aug · 3w ago

8 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·18 Aug · 3w ago

Neutral / worth noting (14)

Colgate Palmolive Share Price - Live NSE: COLPAL Stock Price & Chart

NewsGoogle News·28 Aug · 1w ago

Colgate-Palmolive India MD & CEO Prabha Narasimhan quits, promoted to global role

NewsCnbc-Tv18·21 Aug · 2w ago

Mr. Manish Anandani has been appointed as the new Managing Director & CEO of Colgate Palmolive (India) Limited, effective September 28, 2026.

NSE · Appointment·21 Aug · 2w ago

Ms. Prabha Narasimhan resigned as MD & CEO effective Sep 27, 2026, due to promotion. Mr. Manish Anandani appointed as new MD & CEO effective Sep 28, 2026, for 5 years, subject to shareholder approval.

BSE · Company Update·21 Aug · 2w ago

Colgate Palmolive (India) Limited announced a change in its Managing Director and CEO following a Board Meeting.

NSE · Outcome of Board Meeting·21 Aug · 2w ago

Weighs against the BUY call (5)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·4 Sept · 2d ago

Colgate-Palmolive internal auditor G. Ramprasad resigns

NewsGoogle News·31 Aug · 6d ago

Colgate-Palmolive India Announces Resignation of Internal Auditor

NewsGoogle News·31 Aug · 6d ago

Colgate-Palmolive stock holds steady as insider plans $920,000 share sale

NewsGoogle News·25 Aug · 2w ago

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·24 Oct · 11mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Colgate Palmolive (India) Limited — Citigroup

AI Assessment